Contrastive Machine Learning Reveals the Molecular Profile of Omalizumab Responders in Type 2 Asthma.

J.I. Witonsky, A. Gorla, J. Elhawary, Z.J. Chen, J. Mefford, J. Perez-Garcia, S. Huntsman, D. Hu, C. Eng, P. Woodruff, S. Sankararaman, E. Ziv, J. Flint, N. Zaitlen, E.G. Burchard, E. Rahmani. Contrastive Machine Learning Reveals the Molecular Profile of Omalizumab Responders in Type 2 Asthma. American Journal of Respiratory and Critical Care Medicine. 2025 May 1; 211(Abstracts):a7771-a7771.

2025
https://researcherprofiles.org/profile/613784665

J.I. Witonsky, A. Gorla, J. Elhawary, Z.J. Chen, J. Mefford, J. Perez-Garcia, S. Huntsman, D. Hu, C. Eng, P. Woodruff, S. Sankararaman, E. Ziv, J. Flint, N. Zaitlen, E.G. Burchard, E. Rahmani